$CVS · Parkev Tatevosian, CFA · 2026-11-04
据报道，CVS 计划分拆其零售药房业务，该业务面临门店客流减少和工资上涨的压力；说话者认为这是积极进展，使其对 CVS 的长期前景更为乐观，并以较低的信心和把握重申买入评级。CVS 股价为 91.41 美元，低于其超过 120 美元的公允价值估计；其 10.72 倍的远期市盈率低于华尔街约 12% 的每股收益增长预期，但超过 740 亿美元的长期债务是主要担忧。
逐段跳播
CVS 股票的投资者迎来了重大消息：据彭博社报道，该公司正在讨论剥离其零售药房业务的计划。这可能是一项规模巨大的工程，因为无论从过去十二个月的营收还是现有门店数量来看，CVS Health 都是全球最大的公司之一。
We have huge news for CVS stock investors, as Bloomberg reports that the company is discussing plans to spin off its retail pharmacy business. This could be a huge undertaking, given that CVS Health is one of the largest companies in the world, both in terms of its revenue over the past twelve months and the number of its existing locations.
因此，我想讨论一下这一公告的细节、市场反应、我如何对 CVS 估值，以及我对该公司公允价值的估计。你大概知道，过去十年的大部分时间里，传统门店销售一直在下滑，因为消费者转向了网购，减少了到店次数。
Therefore, I wanted to discuss the details of this announcement, the market reaction, how I value CVS, and what my estimate of the fair value of this company is. As you probably know, traditional store sales have declined for most of the past decade, as consumers have shifted to online shopping and reduced their visits to stores.
这使得管理一个拥有近9000家零售药房的组织成为一件困难的事，尤其是这些门店的员工工资还在持续上涨。
This makes managing an organization with nearly 9,000 retail pharmacies a difficult process, especially with the continued rise in employee wages at those locations.
目前各州正在陆续通过最低工资相关法律，这推高了必须支付的成本。鉴于这些动态，也就是顾客到店减少和运营成本上升，情况看起来并不乐观。
Minimum wage laws are currently being passed in various states, increasing the costs that must be paid. Given these dynamics, namely fewer customer visits and higher operating costs, the situation does not look good.
因此，公司寻求退出这些业务的办法是可以理解的。他们已经关闭了数百家门店，而且即使退出流程尚未完成，如果他们为了改善对顾客的服务而继续关闭更多门店，我也不会感到意外。
Therefore, it is understandable that the company would look for ways to exit these activities. They have already closed hundreds of sites, and I wouldn't be surprised if they continued this trend of closing more sites even if the exit process is not completed, in an effort to improve the service provided to customers.
在《金融时报》报道之后，CVS 股价在盘后交易中一度上涨3.7%。
CVS shares rose as much as 3.7% in after-hours trading following the Financial Times report.
CVS 的一位代表没有立即回应置评请求。像这样规模的公司要推进这种剥离流程，并不是一件容易管理的事。因此，细节会慢慢浮出水面，管理层可能希望按自己的节奏来，在下一季度的投资者更新中讨论此事。
A representative for CVS did not immediately respond to a request for comment. A company of this size undertaking a divestment process of this kind is not an easy task to manage.
Therefore, details will be slow to emerge, and management may wish to do so at its own pace, discussing the matter in the next quarterly investor update.
不过，如果传闻继续扩散，而管理层又持续关注股价对这些进展的反应，它可能被迫出面，向投资者提供更多细节。自2026年初以来，CVS 股价已经上涨了15%，这还不包括股息派发。
However, if the rumors continue to spread, and management continues to monitor the stock price's reaction to these developments, it may be forced to come out and provide more details to investors.
CVS stock has already risen by 15% since the beginning of 2026, in addition to dividend payouts.
它一直是表现最好的股票之一，尤其是按风险调整后的口径衡量时。这不是一只高风险股票。事实上，它是最不具风险的股票之一。
It has been one of the best performing stocks, especially when measured on a risk-adjusted basis. This is not one of the high-risk stocks. In fact, it is one of the least risky stocks.
作为一家医疗保健公司，它与宏观经济表现的相关性不像其他一些更具周期性的公司那么强。全年我都把这只股票评为买入机会，我最近一次更新是在2026年8月13日，当时我再次给出评级，以较低的信心和把握程度重申了买入建议。
As a healthcare company, it is not as strongly correlated with macroeconomic performance as some other, more cyclical companies. I have rated this stock as a buy opportunity throughout the year, and my last update was on August 13, 2026, when I rated it again, reaffirming my buy recommendation with a low level of confidence and conviction.
有意思的是，跟踪 CVS 的华尔街分析师预计，未来几年 CVS 的每股收益增长率约为12%。
Interestingly, Wall Street analysts who follow CVS are forecasting earnings per share growth of around 12% for CVS over the next few years.
这对投资者来说会是一个积极的结果。对于一家处于这个成熟行业、门店在关闭而不是新开的公司来说，每股收益实现翻倍增长，如果公司真的能在未来几年实现这些业绩，那就是非常成功的成果。
That would be a positive outcome for investors. Double earnings per share growth for a company in this mature sector, with stores closing instead of opening new ones, is a very successful outcome if the company actually achieves these results over the next few years.
关于 CVS 最大的担忧之一就是它庞大的债务规模。该公司目前长期债务总额超过740亿美元。它是美国负债最重的公司之一。
One of the biggest concerns about CVS is its large debt balance. The company now has over $74 billion in total long-term debt. It is one of the most indebted companies in the United States.
因此，该股目前的远期市盈率为10.72，这个数字——如果你还记得的话——低于跟踪 CVS 的华尔街分析师所预测的长期每股收益增长预期。
Therefore, the stock is trading at a forward price-to-earnings ratio of 10.72, a figure that—if you recall—is lower than the long-term earnings per share growth estimates projected by Wall Street analysts who follow CVS.
通常，我把这视为积极信号；当一家公司的每股收益预期增速高于其未来盈利倍数时，这是非常有吸引力的局面。这是一个非常有吸引力的评级。它是看待市盈率相对盈利增长比率（PEG）的另一种方式。
Typically, I see this as a positive, and it's a very attractive situation when a company is expected to grow its earnings per share at a rate greater than its future earnings multiple.
This is a very attractive rating. It's another way of looking at the price-to-earnings-to-growth (PEG) ratio.
因此，我也借此机会更新了我对 CVS 折现现金流的评估。由于公司在2026年表现更好，我上调了估值，这不仅体现在股价上，也体现在业务表现上。
Therefore, I also took this opportunity to update my assessment of CVS' discounted cash flows. I have raised my estimates due to the company's better performance here in 2026, not only in terms of share price, but also in terms of business performance.
我估计其公允价值超过120美元，而截至今天收盘（不含盘后交易），该股报91.41美元，相比我估算的公允价值，当前价格还有超过30%的上涨空间。
I estimate the fair value at over $120, and as of today's market close, excluding after-hours trading, the stock was trading at $91.41, leaving room for an increase of over 30% in its current price compared to my estimate of the fair value.
所以，回答我在标题中提出的问题：我确实认为这只股票代表着一个买入机会。这一消息是积极进展，让我对公司的长期前景更加乐观。
So, to answer the question I posed in the title, I do believe that this stock represents a buying opportunity. This news is a positive development, making me more optimistic about the company's long-term prospects.
今天，2026年11月3日，我重申对 CVS 股票的买入评级。
I will reaffirm my buy rating today, November 3, 2026, for CVS stock.